To kick things off, we'll set the stage on what defines non-muscle invasive bladder cancer and how we triage patient ...
The PIVOT-006 trial is part of a larger national effort to evaluate cretostimogene’s safety and effectiveness in bladder ...
As September concludes, the landscape of GU oncology continues to evolve, with important developments in prostate, bladder, ...
Discover a study exploring how bladder cancer organoids advance personalised drug testing, reveal tumour heterogeneity, and ...
Bipolar transurethral resection represents a significant evolution in the surgical management of bladder cancer, particularly for non‐muscle invasive bladder cancer (NMIBC). This technique utilises an ...
Bladder perforation during transurethral resection (TUR) of superficial bladder tumors is associated with worse outcomes, investigators reported in the World Journal of Urology (2014;32:1219–1223).
Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ ...
A person may need surgery for bladder cancer to remove the tumor. A person may also need preoperative or postoperative treatments. Bladder cancer occurs when cells of the bladder start to grow out of ...
Investigators observe no significant difference between the surgical approaches in 1-year progression rates. En bloc resection has the potential to improve outcomes in patients with non-muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback